Access Genetics dba OralDNA® Labs acquires Breakthrough Point-of-Care Rapid PCR Technology from Sensible Diagnostics Inc.
Oct 22, 2024•about 1 year ago
Acquiring Company
OralDNA® Labs
Acquired Company
Sensible Diagnostics
Description
Access Genetics dba OralDNA® Labs proudly announces the acquisition of Sensible Diagnostics Inc., and the assets of their patent-pending real-time quantitative PCR testing platform. With this acquisition, Access Genetics dba OralDNA® Labs aims to commercialize a new standard in point-of-care molecular diagnostics, offering speed and affordability, reinforcing their commitment to innovation in healthcare diagnostics.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed